Unitron expands global footprint with new U.S. subsidiary

Reason for expansion

The U.S. expansion is a strategic step in Unitron’s global growth plan. It reflects the increasing demand from medical device companies for development and manufacturing partners that combine international scope with local support.

“The U.S. market is the global epicenter of medical technology innovation. By establishing a presence here, we can work more closely with our customers and provide them with the speed, quality, and regulatory confidence needed to bring transformative devices to market,” said Pieter De Wilde, CEO of Unitron Medx.

Unitron has built long-term partnerships with MedTech companies across Europe and beyond, supporting them from concept through scale-up and commercialization.

With the addition of the U.S. operation, Unitron strengthens its ability to support emerging growth companies as well as established MedTech players in one of the most dynamic healthcare markets worldwide.

About Unitron Group

Founded in 1988, Unitron is an independent CDMO. The company offers end-to-end services including R&D, industrialization, regulatory support, and contract manufacturing. Unitron is known for its collaborative culture, high quality standards, and long-term partnerships that help MedTech innovators accelerate market access and improve patient care.